Edition:
United States

Verona Pharma PLC (VRNA.OQ)

VRNA.OQ on NASDAQ Stock Exchange Global Market

11.75USD
18 Oct 2018
Change (% chg)

$-0.30 (-2.49%)
Prev Close
$12.05
Open
$12.05
Day's High
$12.05
Day's Low
$11.75
Volume
310
Avg. Vol
959
52-wk High
$25.01
52-wk Low
$10.44

Chart for

About

Verona Pharma plc is a United Kingdom-based clinical-stage biopharmaceutical company. The principal activity of the Company is the development of drugs for the treatment of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis. The Company's product candidate, RPL554, is a... (more)

Overall

Beta: 1.05
Market Cap(Mil.): £149.65
Shares Outstanding(Mil.): 105.02
Dividend: --
Yield (%): --

Financials

  VRNA.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -0.15 -- --
ROI: -17.35 0.45 14.28
ROE: -17.50 1.37 16.00

BRIEF-Verona Pharma Files For Mixed Shelf Of Upto $200 Mln

* VERONA PHARMA PLC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: (https://bit.ly/2rZgygq) Further company coverage:

May 22 2018

Earnings vs. Estimates